Atlas Venture Fund XI, L.P. Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
6
Insider Buys Sum
$26.74M
Insider Sells Quantity
15
Insider Sells Sum
$43.22M

Insider Activity of Atlas Venture Fund XI, L.P.

Biography of Atlas Venture Fund XI, L.P.

No biography is available at this moment.

2024-02-28SaleDyne Therapeutics, Inc.
DYN
10 percent owner
190,920
0.1522%
$24.84$4.74M+17.61%
2024-02-27SaleDyne Therapeutics, Inc.
DYN
10 percent owner
368,699
0.2889%
$24.41$9M+19.43%
2024-02-26SaleDyne Therapeutics, Inc.
DYN
10 percent owner
248,219
0.189%
$23.72$5.89M+22.21%
2024-02-23SaleDyne Therapeutics, Inc.
DYN
10 percent owner
196,928
0.1435%
$22.70$4.47M+29.18%
2024-02-22SaleDyne Therapeutics, Inc.
DYN
10 percent owner
119,360
0.0868%
$22.66$2.7M+31.24%
2024-02-21SaleDyne Therapeutics, Inc.
DYN
10 percent owner
184,501
0.1337%
$22.57$4.16M+30.29%
2024-02-20SaleDyne Therapeutics, Inc.
DYN
10 percent owner
169,539
0.1237%
$22.72$3.85M+29.2%
2024-02-16SaleDyne Therapeutics, Inc.
DYN
10 percent owner
162,707
0.1209%
$23.14$3.77M+28.5%
2024-02-15SaleDyne Therapeutics, Inc.
DYN
10 percent owner
177,906
0.1364%
$23.89$4.25M+24.62%
2024-02-08SaleXilio Therapeutics, Inc.
XLO
10 percent owner
1,000
0.0034%
$0.64$640+57.38%
2024-01-12SaleXilio Therapeutics, Inc.
XLO
10 percent owner
2,100
0.0088%
$0.83$1,743+25.17%
2024-01-11SaleXilio Therapeutics, Inc.
XLO
10 percent owner
2,135
0.0083%
$0.87$1,857+14.46%
2021-12-14SaleImageneBio Inc
IMA
10 percent owner
5,959
0.112%
$14.00$83,426-63.59%
2021-12-13SaleImageneBio Inc
IMA
10 percent owner
8,330
0.1638%
$14.64$121,951-64.74%
2021-12-10SaleImageneBio Inc
IMA
10 percent owner
11,989
0.242%
$15.03$180,195-64.33%
2021-10-26PurchaseXilio Therapeutics, Inc.
XLO
10 percent owner
187,500
0.6839%
$16.00$3M-76.08%
2021-03-30PurchaseImageneBio Inc
IMA
10 percent owner
125,000
2.6856%
$16.00$2M-49.34%
Total: 17
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.